Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RIZZO, Manfredi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.873
EU - Europa 16.751
AS - Asia 15.936
SA - Sud America 3.000
AF - Africa 431
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 23
Totale 66.058
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.437
SG - Singapore 5.957
RU - Federazione Russa 4.432
CN - Cina 3.668
IT - Italia 3.664
BR - Brasile 2.404
VN - Vietnam 1.725
HK - Hong Kong 1.656
DE - Germania 1.609
FI - Finlandia 1.597
PL - Polonia 1.263
UA - Ucraina 1.099
GB - Regno Unito 820
FR - Francia 811
JP - Giappone 796
IE - Irlanda 444
KR - Corea 399
BD - Bangladesh 282
IN - India 278
SE - Svezia 260
AR - Argentina 196
NL - Olanda 185
CA - Canada 177
MX - Messico 162
IQ - Iraq 153
TR - Turchia 139
AT - Austria 116
UZ - Uzbekistan 98
ID - Indonesia 89
RO - Romania 89
EC - Ecuador 85
PK - Pakistan 85
ZA - Sudafrica 85
MA - Marocco 77
CI - Costa d'Avorio 74
CO - Colombia 69
ES - Italia 65
MY - Malesia 65
VE - Venezuela 62
PH - Filippine 58
SA - Arabia Saudita 56
IR - Iran 54
PY - Paraguay 54
BE - Belgio 45
CL - Cile 41
EG - Egitto 41
JO - Giordania 41
TH - Thailandia 39
KE - Kenya 37
CZ - Repubblica Ceca 36
DZ - Algeria 35
GR - Grecia 35
NP - Nepal 35
AE - Emirati Arabi Uniti 34
AU - Australia 34
LB - Libano 34
IL - Israele 32
CH - Svizzera 31
UY - Uruguay 31
PE - Perù 29
AZ - Azerbaigian 26
BO - Bolivia 24
KZ - Kazakistan 21
JM - Giamaica 20
TN - Tunisia 20
TW - Taiwan 19
BH - Bahrain 17
AL - Albania 15
BG - Bulgaria 15
DO - Repubblica Dominicana 15
PA - Panama 15
ET - Etiopia 14
HR - Croazia 14
KG - Kirghizistan 13
LT - Lituania 13
RS - Serbia 13
YE - Yemen 13
EU - Europa 11
HN - Honduras 11
SN - Senegal 11
CR - Costa Rica 9
DK - Danimarca 9
NZ - Nuova Zelanda 9
PT - Portogallo 9
SY - Repubblica araba siriana 9
BA - Bosnia-Erzegovina 8
EE - Estonia 8
HU - Ungheria 8
PS - Palestinian Territory 8
OM - Oman 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AO - Angola 6
BW - Botswana 6
BY - Bielorussia 6
NO - Norvegia 6
SV - El Salvador 6
XK - ???statistics.table.value.countryCode.XK??? 6
BB - Barbados 5
GE - Georgia 5
GY - Guiana 5
Totale 65.965
Salva come PNG Salva come JPEG
Città #
Singapore 3.849
Ashburn 3.565
Fairfield 3.273
San Jose 2.276
Woodbridge 1.605
Chandler 1.592
Hong Kong 1.577
Wilmington 1.417
Houston 1.415
Seattle 1.235
Zgierz 1.171
Cambridge 1.034
Tokyo 776
Moscow 720
Ann Arbor 696
Medford 684
Palermo 663
Santa Clara 622
Council Bluffs 582
Ho Chi Minh City 550
Frankfurt am Main 511
Lauterbourg 510
Beijing 496
Dublin 442
Altamura 441
Jacksonville 441
Princeton 437
Hanoi 410
Los Angeles 399
Nanjing 380
Dallas 370
Hefei 345
Helsinki 320
Des Moines 313
Lawrence 292
New York 285
San Diego 239
Dearborn 226
São Paulo 226
Milan 213
Boardman 210
Chicago 206
Buffalo 184
Tulsa 184
Nuremberg 144
Rome 144
London 140
Ludwigshafen am Rhein 131
Shenyang 128
Hebei 125
Columbus 123
Nanchang 115
Orem 110
Amsterdam 103
Da Nang 101
Changsha 98
Tianjin 95
Jiaxing 91
Jinan 88
Lappeenranta 81
The Dalles 78
Tashkent 77
Abidjan 74
Haiphong 74
Seongnam 73
Guangzhou 72
Rio de Janeiro 70
Warsaw 64
Munich 63
Verona 62
Phoenix 60
Atlanta 59
Zhengzhou 58
Saint Petersburg 57
Krefeld 56
Denver 53
Baghdad 52
Belo Horizonte 52
Ningbo 52
Paris 52
Cardiff 49
Chennai 48
Johannesburg 48
Curitiba 47
Dhaka 45
Montreal 45
San Paolo di Civitate 45
Vienna 45
Brooklyn 44
Orange 44
Salt Lake City 43
Brasília 41
Shanghai 41
Auburn Hills 40
Naples 40
Brussels 39
Mumbai 39
Central 38
Manchester 38
Pune 38
Totale 41.314
Salva come PNG Salva come JPEG
Nome #
LE VESCICOLE EXTRACELLULARI VEGETALI PER LO SVILUPPO DI NUOVI NUTRACEUTICI: STUDIO PRE-CLINICO E CLINICO DELLE PROPRIETÀ BIOLOGICHE DELLE VESCICOLE ISOLATE DA SUCCO DI LIMONE 433
NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet 309
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 301
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 290
Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. 290
A NOVEL THERAPEUTIC APPROACH TO COLORECTAL CANCER IN DIABETES: ROLE OF METFORMIN AND RAPAMYCIN 273
Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis 271
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size 265
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 257
Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. 254
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 251
Who needs to care about small, dense low density lipoproteins? 247
Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction 247
A case of bowel schistosomiasis that did not adhere to the endoscopic findings. 244
The Role of Nutraceuticals in Statin Intolerant Patients 242
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 241
Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study. 230
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 230
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION OR TYPE-II DIABETES 227
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 226
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. 225
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 224
Oral manifestations of inflammatory bowel disease 223
Serum low density lipoprotein subclasses in asthma 219
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions 218
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 218
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 216
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 214
Association between COX-2 rs 6681231 genotype and interleukin-6 in periodontal connective tissue. A pilot study. 212
Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome 211
Efficacy of a fasting‐mimicking diet in functional therapy for depression: A randomised controlled pilot trial 211
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. 210
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 210
Management of Statin Intolerance in 2018: Still More Questions Than Answers 210
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study 207
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease 205
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 204
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 204
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 201
Heat Shock Protein-60 and Risk for Cardiovascular Disease. 201
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels 200
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 199
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction 198
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention. 197
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 197
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 197
High resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD. 196
Medical therapy for patients with subclinical and clinical carotid atherosclerosis 196
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. 194
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 194
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam 194
Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases 193
A Potential Link between Serum Low-Density Lipoproteins and Asthma 193
Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome 192
Therapeutic patient education in oncology: pedagogical notions for women's health and prevention. 190
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 190
The effect of bergamot on dyslipidemia 190
Fever of unknown origin in a mediterranean survey from a division of internal medicine: report of 91 cases during a twelve-year-period (1991-2002) 189
An update on the role of markers of inflammation in atherosclerosis 187
Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis 187
Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects. 186
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome 186
The malnutrition in the elderly: a clinical approach. 185
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? 185
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 185
Androgen excess and cardiovascular risk. 184
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 184
Febbre di origine sconosciuta (FUO): due casisitiche di una medesima divisione di medicina interna a confronto 184
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 184
Anti-cytokine therapy for prevention of atherosclerosis 183
Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. 182
Emerging approaches for the treatment of hypertriglyceridemia. 182
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. 181
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 181
The clinical significance of small, dense low-density lipoproteins 180
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 180
The atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. 179
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 178
Effects of aging and diet on cardioprotection and cardiometabolic risk markers 177
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates 177
PROGNOSTIC IMPACT OF HYPERTENSION AND CAROTID LESIONS IN A FIVE YEARS FOLLOW UP 176
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy-A meta-analysis of 11 randomized controlled trials involving 21,295 participants 176
LA PRESENZA DI ELEVATI LIVELLI DI FIBRINOGENO E PROTEINA C-REATTIVA SONO SIGNIFICATIVAMENTE ASSOCIATI ALLA PRESENZA DI ATEROSCLEROSI CAROTIDEA NEI PAZIENTI IPERTESI O DIABETICI. 175
Small, dense low-density-lipoproteins and the metabolic syndrome. 174
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 173
Diabetes, family hystory and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study 173
Oxidative stress markers at birth: Analyses of a neonatal population 173
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy 173
ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON) 172
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. 172
Uso degli stent medicati con rapamicina in pazienti con situazioni anatomiche o cliniche che favoriscono la restenosi: risultati del follow-up di 6 mesi su primi 100 pazienti 172
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 172
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome 172
Le LDL generate in fase post-prandiale dopo carico grasso presentano maggiore densita’, minore size e maggiore affinita’ per il recettore 170
The role of small, dense low-density lipoproteins in non-coronary forms of atherosclerosis. 169
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect 169
An evaluation of RVX-208 for the treatment of atherosclerosis 169
Atherogenic dyslipidemia and oxidative stress: a new look 168
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 168
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel 168
Totale 20.521
Salva come PNG Salva come JPEG
Categoria #
all - tutte 259.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 259.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021739 0 0 0 0 0 0 0 0 0 0 272 467
2021/20224.370 183 867 72 184 112 126 182 210 489 857 209 879
2022/20235.637 591 1.037 73 461 667 740 262 430 906 59 316 95
2023/20242.858 137 354 191 231 237 712 321 204 71 88 73 239
2024/20258.958 299 719 764 826 269 201 786 637 683 1.029 841 1.904
2025/202627.364 1.553 876 1.895 2.335 2.145 3.454 4.021 3.101 2.961 4.048 975 0
Totale 68.271